{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,29]],"date-time":"2026-10-29T22:22:04Z","timestamp":1793312524643,"version":"4.5.0"},"reference-count":26,"publisher":"Springer Science and Business Media LLC","license":[{"start":{"date-parts":[[2026,4,10]],"date-time":"2026-04-10T00:00:00Z","timestamp":1775779200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,4,10]],"date-time":"2026-04-10T00:00:00Z","timestamp":1775779200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"name":"National Natural Foundation Science of China","award":["NSFC82303274"],"award-info":[{"award-number":["NSFC82303274"]}]},{"name":"National Natural Foundation Science of China","award":["NSFC81802597"],"award-info":[{"award-number":["NSFC81802597"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Virchows Arch"],"DOI":"10.1007\/s00428-026-04509-y","type":"journal-article","created":{"date-parts":[[2026,4,9]],"date-time":"2026-04-09T23:04:48Z","timestamp":1775775888000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Clinicopathological and molecular characteristics of rare ovarian sex cord stromal tumors with BAP1 mutation"],"prefix":"10.1007","author":[{"given":"Hui","family":"Li","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qianlan","family":"Yao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wentao","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoyu","family":"Tu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoyan","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1217-1838","authenticated-orcid":false,"given":"Rui","family":"Bi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,4,10]]},"reference":[{"issue":"8","key":"4509_CR1","doi-asserted-by":"publisher","first-page":"1103","DOI":"10.1158\/2159-8290.CD-19-1220","volume":"10","author":"M Carbone","year":"2020","unstructured":"Carbone M, Harbour JW, Brugarolas J et al (2020) Biological mechanisms and clinical significance of BAP1 mutations in human cancer. Cancer Discov 10(8):1103\u20131120","journal-title":"Cancer Discov"},{"issue":"Suppl 1","key":"4509_CR2","doi-asserted-by":"publisher","first-page":"S60","DOI":"10.21037\/tlcr.2019.11.24","volume":"9","author":"DA Kobrinski","year":"2020","unstructured":"Kobrinski DA, Yang H, Kittaneh M (2020) BAP1: role in carcinogenesis and clinical implications. Transl Lung Cancer Res 9(Suppl 1):S60\u2013S66","journal-title":"Transl Lung Cancer Res"},{"key":"4509_CR3","volume":"2022","author":"D Pandithan","year":"2022","unstructured":"Pandithan D, Klebe S, McKavanagh G et al (2022) BAP1 tumour predisposition syndrome due to whole BAP1 gene deletion. Case Rep Genet 2022:5503505","journal-title":"Case Rep Genet"},{"key":"4509_CR4","doi-asserted-by":"publisher","DOI":"10.1186\/1479-5876-10-179","volume":"10","author":"M Carbone","year":"2012","unstructured":"Carbone M, Ferris LK, Baumann F et al (2012) BAP1 cancer syndrome: malignant mesothelioma, uveal and cutaneous melanoma, and MBAITs. J Transl Med 10:179","journal-title":"J Transl Med"},{"issue":"10","key":"4509_CR5","doi-asserted-by":"publisher","first-page":"1018","DOI":"10.1038\/ng.910","volume":"43","author":"T Wiesner","year":"2011","unstructured":"Wiesner T, Obenauf AC, Murali R et al (2011) Germline mutations in BAP1 predispose to melanocytic tumors. Nat Genet 43(10):1018\u20131021","journal-title":"Nat Genet"},{"issue":"7","key":"4509_CR6","doi-asserted-by":"publisher","first-page":"751","DOI":"10.1038\/ng.2323","volume":"44","author":"S Pena-Llopis","year":"2012","unstructured":"Pena-Llopis S, Vega-Rubin-de-Celis S, Liao A et al (2012) BAP1 loss defines a new class of renal cell carcinoma. Nat Genet 44(7):751\u2013759","journal-title":"Nat Genet"},{"issue":"33","key":"4509_CR7","doi-asserted-by":"publisher","first-page":"13618","DOI":"10.1073\/pnas.1105887108","volume":"108","author":"M Carbone","year":"2011","unstructured":"Carbone M, Baris YI, Bertino P et al (2011) Erionite exposure in North Dakota and Turkish villages with mesothelioma. Proc Natl Acad Sci U S A 108(33):13618\u201313623","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"5","key":"4509_CR8","doi-asserted-by":"publisher","first-page":"921","DOI":"10.1007\/s12282-022-01354-0","volume":"29","author":"A Blatnik","year":"2022","unstructured":"Blatnik A, Ribnikar D, Setrajcic Dragos V et al (2022) BAP1-defficient breast cancer in a patient with BAP1 cancer syndrome. Breast Cancer 29(5):921\u2013927","journal-title":"Breast Cancer"},{"issue":"1","key":"4509_CR9","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1097\/PGP.0000000000000855","volume":"42","author":"BB Albright","year":"2023","unstructured":"Albright BB, Wignall E, Bentley RC et al (2023) BAP1 tumor predisposition syndrome presenting as a recurrent ovarian sex cord-stromal tumor. Int J Gynecol Pathol 42(1):83\u201388","journal-title":"Int J Gynecol Pathol"},{"issue":"1","key":"4509_CR10","doi-asserted-by":"publisher","first-page":"285","DOI":"10.1073\/pnas.1309085110","volume":"111","author":"H Yu","year":"2014","unstructured":"Yu H, Pak H, Hammond-Martel I et al (2014) Tumor suppressor and deubiquitinase BAP1 promotes DNA double-strand break repair. Proc Natl Acad Sci U S A 111(1):285\u2013290","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"6101","key":"4509_CR11","doi-asserted-by":"publisher","first-page":"1541","DOI":"10.1126\/science.1221711","volume":"337","author":"A Dey","year":"2012","unstructured":"Dey A, Seshasayee D, Noubade R et al (2012) Loss of the tumor suppressor BAP1 causes myeloid transformation. Science 337(6101):1541\u20131546","journal-title":"Science"},{"issue":"9","key":"4509_CR12","doi-asserted-by":"publisher","first-page":"2836","DOI":"10.1158\/0008-5472.CAN-15-3371","volume":"76","author":"Y Kadariya","year":"2016","unstructured":"Kadariya Y, Cheung M, Xu J et al (2016) Bap1 is a bona fide tumor suppressor: genetic evidence from mouse models carrying heterozygous germline Bap1 mutations. Cancer Res 76(9):2836\u20132844","journal-title":"Cancer Res"},{"issue":"3","key":"4509_CR13","doi-asserted-by":"publisher","first-page":"307","DOI":"10.1007\/s10689-022-00321-0","volume":"22","author":"L Byrne","year":"2023","unstructured":"Byrne L, Ingalls C, Ansari A et al (2023) Two unique BAP1 pathogenic variants identified in the same family by panel cascade testing. Fam Cancer 22(3):307\u2013311","journal-title":"Fam Cancer"},{"issue":"12","key":"4509_CR14","doi-asserted-by":"publisher","first-page":"1328","DOI":"10.1093\/jnci\/djy171","volume":"110","author":"S Walpole","year":"2018","unstructured":"Walpole S, Pritchard AL, Cebulla CM et al (2018) Comprehensive study of the clinical phenotype of germline BAP1 variant-carrying families worldwide. J Natl Cancer Inst 110(12):1328\u20131341","journal-title":"J Natl Cancer Inst"},{"issue":"7","key":"4509_CR15","doi-asserted-by":"publisher","first-page":"1434","DOI":"10.1038\/s41588-024-01799-3","volume":"56","author":"AJ Waters","year":"2024","unstructured":"Waters AJ, Brendler-Spaeth T, Smith D et al (2024) Saturation genome editing of BAP1 functionally classifies somatic and germline variants. Nat Genet 56(7):1434\u20131445","journal-title":"Nat Genet"},{"issue":"4","key":"4509_CR16","doi-asserted-by":"publisher","DOI":"10.1093\/narcan\/zcae045","volume":"6","author":"IR Sturgill","year":"2024","unstructured":"Sturgill IR, Raab JR, Hoadley KA (2024) Expanded detection and impact of BAP1 alterations in cancer. NAR Cancer 6(4):zcae045","journal-title":"NAR Cancer"},{"issue":"1","key":"4509_CR17","doi-asserted-by":"publisher","first-page":"122","DOI":"10.1186\/s12967-015-0485-1","volume":"13","author":"H Alakus","year":"2015","unstructured":"Alakus H, Yost SE, Woo B et al (2015) BAP1 mutation is a frequent somatic event in peritoneal malignant mesothelioma. J Transl Med 13:122","journal-title":"J Transl Med"},{"issue":"22","key":"4509_CR18","doi-asserted-by":"publisher","first-page":"4108","DOI":"10.7150\/jca.27281","volume":"9","author":"S Jin","year":"2018","unstructured":"Jin S, Wu J, Zhu Y et al (2018) Comprehensive analysis of BAP1 somatic mutation in clear cell renal cell carcinoma to explore potential mechanisms in silico. J Cancer 9(22):4108\u20134116","journal-title":"J Cancer"},{"issue":"20","key":"4509_CR19","doi-asserted-by":"publisher","first-page":"4456","DOI":"10.1158\/1078-0432.CCR-21-4183","volume":"28","author":"B Manning-Geist","year":"2022","unstructured":"Manning-Geist B, Gordhandas S, Liu YL et al (2022) MAPK pathway genetic alterations are associated with prolonged overall survival in low-grade serous ovarian carcinoma. Clin Cancer Res 28(20):4456\u20134465","journal-title":"Clin Cancer Res"},{"issue":"2","key":"4509_CR20","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1136\/ijgc-2020-002018","volume":"31","author":"R Al Harbi","year":"2021","unstructured":"Al Harbi R, McNeish IA, El-Bahrawy M (2021) Ovarian sex cord-stromal tumors: an update on clinical features, molecular changes, and management. Int J Gynecol Cancer 31(2):161\u2013168","journal-title":"Int J Gynecol Cancer"},{"issue":"4","key":"4509_CR21","doi-asserted-by":"publisher","first-page":"333","DOI":"10.1016\/j.clgc.2021.02.002","volume":"19","author":"B Kruslin","year":"2021","unstructured":"Kruslin B, Gatalica Z, Hes O et al (2021) TERT gene fusions characterize a subset of metastatic leydig cell tumors. Clin Genitourin Cancer 19(4):333\u2013338","journal-title":"Clin Genitourin Cancer"},{"issue":"12","key":"4509_CR22","doi-asserted-by":"publisher","first-page":"1398","DOI":"10.1097\/PAS.0000000000002124","volume":"47","author":"RP Mendoza","year":"2023","unstructured":"Mendoza RP, Wang P, Smith HL et al (2023) Clinicopathologic analysis and molecular profiling of ovarian steroid cell tumors. Am J Surg Pathol 47(12):1398\u20131408","journal-title":"Am J Surg Pathol"},{"issue":"5","key":"4509_CR23","doi-asserted-by":"publisher","first-page":"426","DOI":"10.1093\/hmg\/ddad193","volume":"33","author":"PE Repo","year":"2024","unstructured":"Repo PE, Backlund MP, Kivela TT et al (2024) Functional assay for assessment of pathogenicity of BAP1 variants. Hum Mol Genet 33(5):426\u2013434","journal-title":"Hum Mol Genet"},{"issue":"6","key":"4509_CR24","doi-asserted-by":"publisher","first-page":"873","DOI":"10.1007\/s00428-023-03593-8","volume":"483","author":"N Vitlarov","year":"2023","unstructured":"Vitlarov N, Burtscher E, Pfeiffenberger E et al (2023) Peritoneal papillary mesothelioma in situ: BAP1 mutation with indolent behavior for 15 years. Virchows Arch 483(6):873\u2013878","journal-title":"Virchows Arch"},{"issue":"8","key":"4509_CR25","doi-asserted-by":"publisher","first-page":"1061","DOI":"10.1097\/PAS.0000000000001677","volume":"45","author":"JA Bennett","year":"2021","unstructured":"Bennett JA, Young RH, Howitt BE et al (2021) A distinctive adnexal (usually paratubal) neoplasm often associated with Peutz-Jeghers syndrome and characterized by STK11 alterations (STK11 adnexal tumor): a report of 22 cases. Am J Surg Pathol 45(8):1061\u20131074","journal-title":"Am J Surg Pathol"},{"issue":"8","key":"4509_CR26","doi-asserted-by":"publisher","first-page":"838","DOI":"10.1001\/jamadermatol.2024.1804","volume":"160","author":"A Lebensohn","year":"2024","unstructured":"Lebensohn A, Ghafoor A, Bloomquist L et al (2024) Multiple onychopapillomas and BAP1 tumor predisposition syndrome. JAMA Dermatol 160(8):838\u2013845","journal-title":"JAMA Dermatol"}],"container-title":["Virchows Archiv"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00428-026-04509-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00428-026-04509-y","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00428-026-04509-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,9]],"date-time":"2026-04-09T23:04:48Z","timestamp":1775775888000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00428-026-04509-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4,10]]},"references-count":26,"alternative-id":["4509"],"URL":"https:\/\/doi.org\/10.1007\/s00428-026-04509-y","relation":{},"ISSN":["0945-6317","1432-2307"],"issn-type":[{"value":"0945-6317","type":"print"},{"value":"1432-2307","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,4,10]]},"assertion":[{"value":"25 January 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 March 2026","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"31 March 2026","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 April 2026","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors have no conflicts of interest to declare.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}